Skip to content

Talphera, Inc. TLPH Market capitalization

Market capitalization at other companies

Baxter International logo
Baxter InternationalBAX
$8.67B-50.6%
AMP
Amphastar PharmaceuticalsAMPH
$888.8M-35.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06B+95.0%
Royalty Pharma logo
Royalty PharmaRPRX
$20.55B+52.4%
PTH
Pelthos Therapeutics Inc.PTHS
$70.5M
XOMA Corporation logo
XOMA CorporationXOMA
$373.48M+56.4%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Computed from the period-end share price: $37.38M.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s market capitalization?
Talphera, Inc. (TLPH) reported market capitalization of $37.38M in Q1 2026.
How has Talphera, Inc.'s market capitalization changed year-over-year?
Talphera, Inc.'s market capitalization increased by 343.5% year-over-year, from $8.43M to $37.38M.
What is the long-term trend for Talphera, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Talphera, Inc.'s market capitalization has grown at a -14.2% compound annual growth rate (CAGR), from $114.44M to $53.13M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.